Answers are grounded in this paper and cite their sources.
This Viewpoint characterizes incidental radiographic findings from clinical trial–related imaging as an underrecognized potential harm of trial participation and proposes practices and standards to more systematically include them as a trial safety end point.
No takes yet. Share an insight, caveat, or question.
Oren et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: